fbpx Skip to main content

Member's Profile

Allogene Therapeutics

Location
210 EAST GRAND AVENUE
South San Francisco,   CA
94080
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2019
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Allogene Therapeutics
Biotech Company
Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.

AlloCAR T™ cell therapies are engineered from cells of healthy donors, which is intended to allow for creation of inventory for on demand use in patients. This approach is designed to eliminate the need to create…
Related News
No related news posted by this Member